News
GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback